Vitamin E may delay decline and ease symptoms of Alzheimer’s disease
by Newsletter Editor
In this study across 14 Veterans Affairs Medical Centers, 561 people with mild to moderate Alzheimer’s disease took 2,000 IU of vitamin E per day, 20 mg per day of the memory-loss drug Memantine; these two together, or a placebo. After more than two years of follow-up, compared to placebo, doctors found vitamin E delayed the decline in daily functioning activities by 19 percent, or by more than six months.
Researchers also looked at changes in the amount of caregiver time and found those who took vitamin E alone had the smallest increase in time required of caregivers.
This is the first clinical trial to show an added benefit for vitamin E in mild to moderate Alzheimer’s disease and, because vitamin E is inexpensive and readily available, it should be part of treatment, doctors said.